Navigation Links
B. Braun Receives FDA Approval For New Large-Volume Irrigation Containers
Date:9/23/2013

BETHLEHEM, Pa., Sept. 23, 2013 /PRNewswire/ -- B. Braun Medical Inc. (B.Braun), a leader in infusion therapy and pain management, announced today that it has received FDA approval of 0.9% Sodium Chloride for Irrigation in 2L and 3L containers. The approval initiates B.Braun's launch of TITAN® XL, a line of flexible bags that offers large-volume irrigation and parenteral nutrition solutions for compounding.

B.Braun continues to lead the way in the healthcare industry by impacting the way hospitals evaluate and purchase their products – a true testament to B.Braun's ecological awareness and patient-centric philosophy. With the addition of the new TITAN XL containers, B.Braun will expand its line of fluid products that are not manufactured with natural rubber latex, DEHP or PVC. Exposure to these toxic materials has been a growing concern for healthcare facilities around the world. Studies show that excessive exposure to DEHP can potentially lead to adverse health effects, especially to a patient's liver, kidneys and lungs, as well as their heart rate and blood pressure.[1] More than three decades ago, B.Braun recognized the environmental and patient risks posed by products containing DEHP and PVC. As a result, B.Braun was the first medical device manufacturer to remove these harmful substances from many products and today is the only supplier that offers a full line of IV containers that are not manufactured with DEHP or PVC. B.Braun is keenly focused on continuing to find alternative methods to manufacture safer products such as the TITAN XL irrigation bags. 

B.Braun's Rick Williamson, Vice President of Pharmaceutical Marketing has been a key contributor to the recent success of the expanding US drug delivery portfolio. "We listened to the requests of our customers for fluid containers that are focused on patient safety and that are environmentally friendly," said Williamson. "We are especially proud to offer the only large-volume containers not manufactured with natural rubber latex, DEHP or PVC."

Customers interested in more information can call: 888.422.7286 (888.4BBRAUN) or visit www.BBraunUSA.com.

About TITAN®

The TITAN® XL containers offer irrigation and parenteral nutrition solutions for compounding in large volume, flexible bags. TITAN XL is highly transparent for quick volume monitoring and the innovative, convenient port system allows for easier access. The TITAN XL container is not manufactured with natural rubber latex, DEHP or PVC and is compatible with most drugs. TITAN XL is stored at room temperature. B.Braun will be launching a series of TITAN XL containers for Irrigation and Clinical Nutrition beginning in September, 2013 and throughout 2014. B.Braun's TITAN XL offerings currently include 3L 0.9% Sodium Chloride for Irrigation.

About B. Braun

B. Braun Medical Inc. (B.Braun), a leader in infusion therapy and pain management, develops, manufactures and markets innovative medical products and services to the healthcare industry. The Company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. Guided by its "Sharing Expertise®" philosophy, B.Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs.

The B.Braun Group of Companies in the U.S. includes B.Braun, Aesculap® and CAPS®. B.Braun's U.S. headquarters is located in Bethlehem, Pennsylvania. The B.Braun Group of Companies employs more than 46,000 employees in more than 50 countries throughout the world. To learn more about B.Braun visit www.BBraunUSA.com.

[1] http://www.wsna.org/Topics/Workplace-Environment-You/Environmental-Hazards/PVC-DEHP/


'/>"/>
SOURCE B. Braun Medical Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. B. Braun Receives FDA Approval For New Large-Volume Intravenous Containers
2. B. Braun to Showcase Its Safety-Engineered IV Therapy Portfolio at AVA
3. B. Braun Awarded Premier Healthcare Alliance Contract for Dual-Source IV
4. Patient and Healthcare Worker Safety Major Areas of Focus at B.Braun
5. B. Braun Smart Infusion Pump Technology to be Featured in Integrating the Healthcare Enterprise (IHE) Interoperability Demonstration at AAMI 2013
6. B. Braun Committed To Improving Patient Safety
7. B. Braun Reveals Customer Satisfaction Survey
8. B. Braun Committed to Protecting Healthcare Workers from Exposure to Hazardous Drugs
9. B. Braun Launches New Patient Website
10. B. Braun Smart Infusion Pump Technology Advances Patient Safety and Treatment Efficiency
11. B. Braun Joins National Health Organization Supporting Environmental Practices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... GERMANTOWN, Maryland , May 25, ... Therawis bedient dringenden Bedarf ... QIAGEN N.V. (NASDAQ: QGEN ; ... Lizenz- und Entwicklungsvereinbarung mit Therawis Diagnostics GmbH zur ... eingegangen zu sein. Ein erstes Projekt wird die ...
(Date:5/25/2016)... Florida , May 25, 2016 ... Conference & Expo earlier this month, the numbers and ... revenues continue to climb into the billions, more research ... newly released 4th Edition State of Legal Marijuana Markets ... a cannabis-focused data-analysis firm, much of the increase in ...
(Date:5/25/2016)... 2016 ReportsnReports.com adds "Chronic ... that provides an overview on therapeutic pipeline of ... stages, therapeutics assessment by drug target, mechanism of ... type, along with latest updates, and featured news ... involved in the therapeutic development for Chronic Cough ...
Breaking Medicine Technology:
(Date:5/26/2016)... ... ... Connor Sports, through its Connor Cares initiative, will continue to expand ... Tour that will commemorate the Indiana Fever legend’s hall-of-fame career and final WNBA ... levels of the game, Connor Sports has committed to a significantly increased focus on ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cardiac arrhythmia is ... impact on long-term patient survival, reports a team of UPMC researchers in the ... in the Journal of Thoracic and Cardiovascular Surgery, provide critical information that will ...
(Date:5/26/2016)... ... May 26, 2016 , ... Catalent ... for drugs, biologics, consumer health and global clinical supply services, today announced two ... support the company’s continued investment and strategic growth plans in the Asia Pacific ...
(Date:5/26/2016)... ... ... to provide hair restoration information to the widest possible audience, Dr. Parsa Mohebi is making ... app. Dr. Mohebi, the founder of Parsa Mohebi Hair Restoration, is making all of his ... says, “The positive response to the Snapchat videos we started last month has been overwhelming. ...
(Date:5/26/2016)... ... May 26, 2016 , ... Eating Recovery Center, Washington ... opening a brand new child and adolescent residential treatment center on June 1. ... even more specialized eating disorder treatment and access to life-saving care. , To ...
Breaking Medicine News(10 mins):